A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Diabetes Mellitus, Type 2
Interventions
DIETARY_SUPPLEMENT

NW Low-Glu®

One NW Low-Glu® capsule contains Mas Cotek powdered Extract 300 mg (from leaves of Ficus deltoidea Jack by aqueous solvent extraction) + Cinnamomum cassia L. powdered Extract 100 mg + Black seed powdered extract 250 mg (from seeds of Nigella sativa L. by 70% hydro-alcoholic extraction).

DRUG

Metformin

Patients in the active comparator arm will receive a total of 2000 mg of metformin per day.

All Listed Sponsors
lead

Natural Wellness Egypt

INDUSTRY